JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32371

Anti-Bak 抗体 [Y164]

Anti-Bak antibody [Y164]

  • BOND RX™ Validated
  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • 詳細を見る

5

(3 Reviews)

|

(73 Publications)

Knockout Tested Rabbit Recombinant Monoclonal BAK antibody. Suitable for IP, WB, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 73 publications.

別名を表示する

BAK, BCL2L7, CDN1, BAK1, Bcl-2 homologous antagonist/killer, Apoptosis regulator BAK, Bcl-2-like protein 7, Bcl2-L-7

14 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)

Immunohistochemical analysis of Bak expression in paraffin embedded human stomach carcinoma, using 1/250 unpurified ab32371.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human pancreatic carcinoma tissue sections labeling Bak with Purified ab32371 at 1 : 200 dilution (2.98 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ab97051 Goat Anti-Rabbit IgG H&L (HRP)
secondary antibody was used at 1 : 500 dilution. PBS instead of the primary antibody was used as the negative control.

Flow Cytometry (Intracellular) - Anti-Bak antibody [Y164] (AB32371)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Bak antibody [Y164] (AB32371)

Flow cytometric analysis of 4% paraformaldehyde fixed, 90% methanol permeabilized BAK1 KO Hela (human BAK1 knockout cervical adenocarcinoma epithelial cell, Left) /Parental Hela (Right) cells labelling Bak with ab32371 at 1/500 dilution (0.1 µg)(Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/5000 dilution was used as the secondary antibody.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)

Immunohistochemical analysis of paraffin-embedded fixed (A) Wild-type HeLa (human cervix adenocarcinoma epithelial cell) cell pellet. (B) BAK1 knockout HeLa (ab265277) cell pellet staining Bak with ab32371 at 1/2000 dilution followed by a ready to use LeicaDS9800 (Bond™ Polymer Refine Detection). Counter-staining used was hematoxylin. Positive staining on (A) Wild-type HeLa cell pellet, no staining on (B) BAK1 knockout HeLa (ab265277) cell pellet. The section was incubated with ab32371 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.

Immunocytochemistry/ Immunofluorescence - Anti-Bak antibody [Y164] (AB32371)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Bak antibody [Y164] (AB32371)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling Bak with Purified ab32371 at 1 : 100 dilution. Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200. ab150077 Goat anti rabbit IgG(Alexa Fluor® 488) was used as the secondary antibody at 1 : 1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Immunocytochemistry/ Immunofluorescence - Anti-Bak antibody [Y164] (AB32371)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Bak antibody [Y164] (AB32371)

ICC/IF image of unpurified ab32371 stained HeLa cells. The cells were 4% PFA fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (unpurified ab32371, 1μg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43μM.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bak antibody [Y164] (AB32371)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human stomach tissue sections labeling Bak with Purified ab32371 at 1 : 200 dilution (2.98 μg/ml). Heat mediated antigen retrieval was performed using ab93684 (Tris/EDTA buffer, pH 9.0). Tissue was counterstained with Hematoxylin. ab97051 Goat Anti-Rabbit IgG H&L (HRP)
secondary antibody was used at 1 : 500 dilution. PBS instead of the primary antibody was used as the negative control.

Immunoprecipitation - Anti-Bak antibody [Y164] (AB32371)
  • IP

Lab

Immunoprecipitation - Anti-Bak antibody [Y164] (AB32371)

ab32371 (purified) at 1 : 20 dilution (2μg) immunoprecipitating Bak in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate.

Lane 1 (input) : HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate 10μg
Lane 2 (+) : ab32371 & HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32371 in HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate

For western blotting, VeriBlot for IP Detection Reagent (HRP) (ab131366) was used for detection at 1 : 1000 dilution.
Blocking and diluting buffer : 5% NFDM/TBST.

All lanes:

Immunoprecipitation - Anti-Bak antibody [Y164] (ab32371)

Predicted band size: 23 kDa

false

Immunoprecipitation - Anti-Bak antibody [Y164] (AB32371)
  • IP

AbReview37813****

Immunoprecipitation - Anti-Bak antibody [Y164] (AB32371)

Bak was immunoprecipitated from HCT116 p53-/- cell line whole cell lysate with unpurified ab32371 at 1/100 dilution.

Western blot was performed from the immunoprecipitate using ab32371 at 1/2000 dilution.

All lanes:

Immunoprecipitation - Anti-Bak antibody [Y164] (ab32371)

Predicted band size: 23 kDa

false

Western blot - Anti-Bak antibody [Y164] (AB32371)
  • WB

Lab

Western blot - Anti-Bak antibody [Y164] (AB32371)

Lanes 1- 2 : Merged signal (red and green). Green - ab32371 observed at 23 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab32371 was shown to react with Bak in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265277 (knockout cell lysate ab257077) was used. Wild-type HeLa and BAK1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32371 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Bak antibody [Y164] (ab32371) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

BAK1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human BAK1 (Bak) knockout HeLa cell line (<a href='/products/cell-lines/human-bak1-bak-knockout-hela-cell-line-ab265277'>ab265277</a>)

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Anti-Bak antibody [Y164] (AB32371)
  • WB

Lab

Western blot - Anti-Bak antibody [Y164] (AB32371)

Lanes 1 - 3 : Merged signal (red and green). Green - ab32371 observed at 25 kDa. Red - loading control, ab9484, observed at 37 kDa.

Unpurified ab32371 was shown to specifically recognize BAK in wild-type HAP1 cells. No band was observed when BAK knockout cells were examined. Wild-type and BAK knockout samples were subjected to SDS-PAGE. Unpurified ab32371 and ab9484 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20,000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Bak antibody [Y164] (ab32371)

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

BAK knockout HAP1 whole cell lysate at 20 µg

Lane 3:

Human Heart whole cell lysate at 20 µg

Predicted band size: 23 kDa

false

Western blot - Anti-Bak antibody [Y164] (AB32371)
  • WB

Lab

Western blot - Anti-Bak antibody [Y164] (AB32371)

Blocking and diluting buffer : 5% NFDM/TBST

All lanes:

Western blot - Anti-Bak antibody [Y164] (ab32371) at 1/10000 dilution

Lane 1:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysates at 20 µg

Lane 2:

HEK-293 (Human embryonic kidney epithelial cell) whole cell lysates at 20 µg

Lane 3:

Human fetal heart lysates at 20 µg

Secondary

All lanes:

Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/2000 dilution

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Anti-Bak antibody [Y164] (AB32371)
  • WB

Unknown

Western blot - Anti-Bak antibody [Y164] (AB32371)

All lanes:

Western blot - Anti-Bak antibody [Y164] (ab32371) at 1/5000 dilution

All lanes:

HeLa cell lysate

Predicted band size: 23 kDa

Observed band size: 23 kDa

false

Western blot - Anti-Bak antibody [Y164] (AB32371)
  • WB

CiteAb

Western blot - Anti-Bak antibody [Y164] (AB32371)

Bak western blot using anti-Bak antibody [Y164] ab32371. Publication image and figure legend from Paolini, F., Zaccarini, M., et al., 2020, Front Cell Infect Microbiol, PubMed 32257968.

ab32371 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab32371 please see the product overview.

HPV15 affects TNF-α-induced apoptosis. HaCaT (A) and HPK (B) cells were utlized. HPV 15 transduction, IKKγ gene silencing and TNF-α treatment (10 ng/ml) for 6 h are indicated. Apoptosis was measured by a Cell Death ELISA test according to manufacturer's instruction in triplicate samples. Error bars = ±SD. ***p < 0.0001 by unpaired t-test. Activation of apoptotic pathway was analyzed in cell lysates by Western blots with anti-cleaved Caspase 3 or anti-BAK antibodies, as described in section Materials and Methods. All these experiments were repeated twice with similar results.

false

関連する標識済み抗体及び組成の異なる製品 (2)

  • HRP

    HRP Anti-Bak antibody [Y164]

  • Carrier free

    Anti-Bak antibody [Y164] - BSA and Azide free

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

Y164

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB, IP, IHC-P, Flow Cyt (Intra)

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

特異性

This antibody recognises Bak. The antibody does not cross-react with other Bcl2 members.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000", "WB-species-notes": "<p><strong>For unpurified use at 1/1000 - 1/5000. </strong></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p><strong>For unpurified use at 1/250-1/500.</strong></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/10 - 1/20", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

製品の詳細

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.21% BSA
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

The Bak protein also known as Bcl-2 homologous antagonist killer plays a mechanical role in the mitochondrial apoptosis pathway. It often functions as a pro-apoptotic member of the Bcl-2 protein family. Bak is expressed widely in the body being present in tissues such as the brain and heart. The molecular weight of Bak is approximately 23 kilodaltons. Bak interacts with other mitochondrial proteins to trigger cell death processes.
Biological function summary

Bak engages in promoting apoptosis by disrupting the mitochondrial outer membrane potential. It is part of the Bcl-2 family complex which balances cell survival and cell death. Bak collaborates with Bax protein to form pores in the mitochondrial membrane releasing cytochrome c and other apoptotic factors. This process initiates the cascade of caspases leading to programmed cell death.

Pathways

Bak is a critical component of the intrinsic apoptotic pathway. It directly interacts with pro-apoptotic proteins like Bax and anti-apoptotic proteins such as Bcl-2 and Bcl-xL. Bak's action in the apoptotic pathway involves a delicate balance between survival and death signals affecting cellular homeostasis. In addition Bak's interaction with the p53 pathway emphasizes its role in response to DNA damage ensuring damaged cells do not proliferate uncontrollably.

Malfunction or dysregulation of Bak can lead to cancer and neurodegenerative disorders. In cancer reduced Bak activity may allow cells to evade apoptosis promoting tumor survival and growth. Conversely in diseases like Parkinson's excessive Bak activity may result in enhanced neuronal apoptosis. Bak's interaction with proteins such as Bcl-2 also makes it a potential target for therapies aimed at restoring apoptotic balance in affected cells.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Plays a role in the mitochondrial apoptotic process. Upon arrival of cell death signals, promotes mitochondrial outer membrane (MOM) permeabilization by oligomerizing to form pores within the MOM. This releases apoptogenic factors into the cytosol, including cytochrome c, promoting the activation of caspase 9 which in turn processes and activates the effector caspases.
See full target information BAK1

文献 (73)

Recent publications for all applications. Explore the full list and refine your search

The Journal of biological chemistry 301:108421 PubMed40113041

2025

Optogenetic tools for inducing organelle membrane rupture.

Applications

Unspecified application

Species

Unspecified reactive species

Yuto Nagashima,Tomoya Eguchi,Ikuko Koyama-Honda,Noboru Mizushima

Nature biomedical engineering 8:1379-1395 PubMed39025942

2024

Profiling protein-protein interactions to predict the efficacy of B-cell-lymphoma-2-homology-3 mimetics for acute myeloid leukaemia.

Applications

Unspecified application

Species

Unspecified reactive species

Changju Chun,Ja Min Byun,Minkwon Cha,Hongwon Lee,Byungsan Choi,Hyunwoo Kim,Saem Hong,Yunseo Lee,Hayoung Park,Youngil Koh,Tae-Young Yoon

Communications medicine 3:154 PubMed37880389

2023

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients.

Applications

Unspecified application

Species

Unspecified reactive species

Junichiro Yuda,Christine Will,Darren C Phillips,Linu Abraham,Cory Alvey,Abraham Avigdor,Wayne Buck,Lauren Besenhofer,Erwin Boghaert,Dong Cheng,Dan Cojocari,Kelly Doyle,T Matthew Hansen,Kevin Huang,Eric F Johnson,Andrew S Judd,Russell A Judge,John C Kalvass,Aaron Kunzer,Lloyd T Lam,Rachel Li,Ruth L Martin,Anthony Mastracchio,Mike Mitten,Adam Petrich,Jin Wang,James E Ward,Haichao Zhang,Xilu Wang,Johannes E Wolff,Katherine M Bell-McGuinn,Andrew J Souers

Cancers 15: PubMed37509312

2023

NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor.

Applications

Unspecified application

Species

Unspecified reactive species

Ramy Ashry,Al-Hassan M Mustafa,Kristin Hausmann,Michael Linnebacher,Susanne Strand,Wolfgang Sippl,Matthias Wirth,Oliver H Krämer

Immunity, inflammation and disease 11:e958 PubMed37506141

2023

STK11 mutation impacts CD1E expression to regulate the differentiation of macrophages in lung adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Qingfeng Zhang,Juan Feng,Kui Liu,Xiaoyan Yang,Yun Huang,Bo Tang

Journal of advanced research 60:201-214 PubMed37467961

2023

Novel hydroxamic acid derivative induces apoptosis and constrains autophagy in leukemic cells.

Applications

Unspecified application

Species

Unspecified reactive species

Marten A Fischer,Al-Hassan M Mustafa,Kristin Hausmann,Ramy Ashry,Anita G Kansy,Magdalena C Liebl,Christina Brachetti,Andrea Piée-Staffa,Matthes Zessin,Hany S Ibrahim,Thomas G Hofmann,Mike Schutkowski,Wolfgang Sippl,Oliver H Krämer

Hereditas 160:30 PubMed37464443

2023

An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Hongjin Wang,Nian Wang,Ze Tang,Qiuyu Liu,Shiyu Nie,Wu Tao

Discover. Oncology 14:28 PubMed36853387

2023

Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Wang,Zhiyong Zhou

Molecular medicine (Cambridge, Mass.) 29:10 PubMed36658493

2023

A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Tianming Zhao,Qiang He,Shurong Xie,Huien Zhan,Cheng Jiang,Shengbin Lin,Fangshu Liu,Cong Wang,Guo Chen,Hui Zeng

Anti-cancer drugs 34:15-28 PubMed36206143

2022

LOC554202 contributes to chordoma progression by sponging miR-377-3p and up-regulating SMAD3.

Applications

Unspecified application

Species

Unspecified reactive species

Guang Xu,Jingnan Liu,Jun He,Haibo He,Xiaotao Su,Qianhuan Gui
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com